WHAT: Warner-Lambert will release findings of a study,
conducted by The Boston Consulting Group (BCG),
measuring the impact of price controls on the three
stakeholders in the health
care debate: patients, government and companies. WHEN: Thursday, April 29
12:00 Noon -- 2:00 PM WHERE: National Press Club
First Amendment Room
529 14th Street, N.W.
Washington, D.C. WHO: Dr. Anthony H. Wild, President, Pharmaceutical Sector,
Warner-Lambert Company Arnon A. Mishkin, Vice
President, Boston Consulting Group Simon J. Goodall,
Project Leader, Boston Consulting Group WHY: In Japan, the U.S. and several countries in Europe,
debate continues to rage over health care reform. This
important study will provide valuable information and
analysis for those policy debates. RSVP TO: Lisa Knapp -- 202-548-0602 Editors Note: A Video News Release and copies of the study will be available. Following their presentations, the participants will be available to answer questions. ots Original Text Service: Warner-Lambert Company Internet: http://www.newsaktuell.de CONTACT: Steve Selby, 202-548-0601, for Warner-Lambert Company.